These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7023616)

  • 1. Characterization of a putative nicotinic acetylcholine receptor in mammalian brain.
    Morley BJ; Kemp GE
    Brain Res; 1981 Aug; 228(1):81-104. PubMed ID: 7023616
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on nicotinic acetylcholine receptors in mammalian brain VI. Isolation of a membrane fraction enriched in receptor function for different neurotransmitters.
    de Blas A; Mahler HR
    Biochem Biophys Res Commun; 1976 Sep; 72(1):24-32. PubMed ID: 985471
    [No Abstract]   [Full Text] [Related]  

  • 3. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinic receptors in sensory ganglia.
    Polz-Tejera G; Hunt SP; Schmidt J
    Brain Res; 1980 Aug; 195(1):223-30. PubMed ID: 6967343
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of nicotinic cholinergic transmission in Malapterurus electricus electroplax.
    Eldefrawi ME; Shaker N; Mansour NA; Warnick JE; Albuquerque EX
    Life Sci; 1981 Sep; 29(10):1033-7. PubMed ID: 7289769
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional and subcellular distribution of cholinergic enzyme and receptor activity in goldfish brain.
    Francis A; Schechter N
    Neuroscience; 1980; 5(2):293-301. PubMed ID: 7374943
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
    Reiness CG; Weinberg CB; Hall ZW
    Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of iodine 125 alpha-bungarotoxin to the thymus of mice.
    Ohshima F; Kondo K; Tsubaki T
    Arch Neurol; 1978 Jan; 35(1):31-2. PubMed ID: 619869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
    Fontana A; Fulpius BW; Cuénoud S
    Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors.
    Oswald RE; Freeman JA
    Neuroscience; 1981; 6(1):1-14. PubMed ID: 7012663
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation rate of nicotinic acetylcholine receptor from goldfish brain.
    Oswald RE; Freeman JA
    Brain Res; 1980 Apr; 187(2):499-503. PubMed ID: 7370746
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a putative nicotinic acetylcholine receptor in fractions from housefly brain [proceedings].
    Harris R; Cattell KJ; Donnellan JF
    Biochem Soc Trans; 1979 Feb; 7(1):136-8. PubMed ID: 437257
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
    Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
    Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
    [No Abstract]   [Full Text] [Related]  

  • 17. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct binding studies of 125 I-alpha-bungarotoxin and 3H-quinuclidinyl benzilate interaction with axon plasma membrane fragments. Evidence for nicotinic and muscarinic binding sites.
    Marquis JK; Hilt DC; Mautner HG
    Biochem Biophys Res Commun; 1977 Sep; 78(2):476-82. PubMed ID: 907696
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain.
    Schwartz RD; McGee R; Kellar KJ
    Mol Pharmacol; 1982 Jul; 22(1):56-62. PubMed ID: 7121451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.